Nov 2, 2020 | Fraud Investigations, Government Investigations, Health Care
Over the last few years, state and federal law enforcement agencies have brought a number of criminal and civil actions to hold pharmaceutical companies accountable for the opioid crisis. The latest milestone in the pursuit of accountability is a DOJ settlement with...
Oct 27, 2020 | Government Investigations, Health Care, White Collar Crime
Earlier this year, a jury found Sylvia Hofstetter guilty of a Racketeer Influenced Corrupt Organization (“RICO”) conspiracy, two counts of drug conspiracy, money laundering, and maintaining a drug-involved premise for her role in operating pill mills in Florida and...
Oct 22, 2020 | DOJ, General, Government Investigations
Yesterday, the Department of Justice (“DOJ”) filed a landmark antitrust case against Google, accusing the tech giant of disadvantaging competitors through a network of allegedly exclusionary business deals regarding searching and online advertising. Eleven states –...
Oct 20, 2020 | Government Investigations, Health Care, White Collar Crime
The False Claims Act has long been considered one of the Department of Justice’s (“DOJ”) most powerful tools for preventing wrongdoing in the healthcare industry. However, the DOJ’s Antitrust Division has been actively investigating anti-competitive behavior in the...
Oct 6, 2020 | False Claims Act, Government Investigations
On September 30, 2020, the U.S. Department of Justice (“DOJ”) issued a press release regarding a nationwide enforcement action involving 345 defendants allegedly responsible for submitting more than $6 billion in fraudulent healthcare claims. According to the DOJ,...
Sep 11, 2020 | COVID-19 Related Law, Government Investigations, White Collar Crime
On September 10, Acting Assistant Attorney General Brian Rabbitt delivered remarks at the PPP Criminal Fraud Enforcement Action Press Conference. A written version of his remarks can be accessed here. The Paycheck Protection Program (PPP) was part of the CARES Act,...
